Human T-Cell Lymphotropic Virus type II infection
What is Human T-Cell Lymphotropic Virus type II infection?
Human T-Cell Lymphotropic Virus type II, or HTLV-II, is a retrovirus that infects certain white blood cells in your body. Retroviruses are viruses that insert their genetic material into your cells, which then stay infected for life. HTLV-II is related to HTLV-I, another retrovirus, but the two cause different health problems.
Most people who have HTLV-II never develop any symptoms or health issues. The virus is much less common than other viral infections and is often discovered during routine blood screening. When symptoms do occur, they can take decades to appear after the initial infection.
While rare, HTLV-II has been linked to a small number of cases of hairy cell leukemia, a slow-growing blood cancer. However, the connection between HTLV-II and disease is not as clear as it is for HTLV-I. Most infected people live normal, healthy lives without ever knowing they carry the virus.
Symptoms
Most people with HTLV-II infection experience no symptoms at all. The virus can remain silent in your body for your entire life. When symptoms do develop, they may include:
- Frequent infections due to changes in immune function
- Unexplained fatigue that does not improve with rest
- Enlarged lymph nodes in the neck, armpits, or groin
- Skin rashes or lesions that come and go
- Weakness or numbness in the legs or feet
- Easy bruising or bleeding
- Night sweats or unexplained fevers
The vast majority of people with HTLV-II remain asymptomatic throughout their lives. If symptoms appear, they typically develop very slowly over many years.
Concerned about Human T-Cell Lymphotropic Virus type II infection? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
HTLV-II spreads through direct contact with infected blood or body fluids. The virus passes from person to person through several routes. Sharing needles for drug use is one of the most common ways people get infected. The virus can also spread through sexual contact, though this is less common than with some other infections. Mothers can pass HTLV-II to their babies during breastfeeding, as the virus is present in breast milk.
Certain groups have higher rates of HTLV-II infection. People who inject drugs have the highest risk due to needle sharing. Indigenous populations in North and South America have higher infection rates than other groups. Blood transfusions were once a risk factor, but modern blood screening has nearly eliminated this route. The virus does not spread through casual contact like hugging, sharing food, or being in the same room with someone who is infected.
How it's diagnosed
HTLV-II is diagnosed through blood tests that look for antibodies your immune system makes against the virus. The HTLV I/II Antibody test is the first step, which detects antibodies to both HTLV-I and HTLV-II. If this screening test is positive, a confirmatory assay follows to verify the results and distinguish between HTLV-I and HTLV-II infection.
Because HTLV-II testing is specialized, it is not part of routine health screenings. Your doctor may order this test if you have risk factors for infection or if you are donating blood or organs. Talk to a doctor about whether HTLV testing is right for you. They can help you understand your risk factors and guide you through the testing process.
Treatment options
Treatment for HTLV-II focuses on monitoring your health and addressing any complications that may develop. Most infected people need no treatment at all. Your care plan may include:
- Regular medical checkups to monitor your blood counts and immune function
- Avoiding behaviors that could spread the virus to others
- Not donating blood, plasma, organs, or tissue
- Choosing formula feeding over breastfeeding if you are pregnant or planning pregnancy
- Practicing safer sex to prevent transmission to partners
- Maintaining a healthy lifestyle with good nutrition and regular exercise
- Avoiding alcohol and tobacco, which can weaken immune function
- Treating any complications like infections or blood disorders if they develop
There is currently no cure for HTLV-II and no antiviral medications proven to eliminate the virus. If rare complications like hairy cell leukemia develop, your doctor will create a specific treatment plan. This may include chemotherapy or other targeted therapies. Work closely with an infectious disease specialist or hematologist if you have HTLV-II infection.
Frequently asked questions
HTLV-I and HTLV-II are both retroviruses, but they cause different health problems. HTLV-I is more strongly linked to diseases like adult T-cell leukemia and a neurological condition called tropical spastic paraparesis. HTLV-II rarely causes disease and most infected people remain healthy for life. Both viruses are detected by the same initial blood test, but confirmatory testing can tell them apart.
No, there is currently no cure for HTLV-II infection. Once the virus enters your cells, it stays there for life. However, most people with HTLV-II never develop any health problems from the infection. There are no antiviral medications that can eliminate the virus from your body.
HTLV-II is quite rare in most populations. It is more common among people who inject drugs and certain indigenous populations in North and South America. The infection is much less common than HTLV-I worldwide. Most people who have HTLV-II only discover it through blood donation screening or specialized testing.
HTLV-II does not spread through casual contact like hugging, kissing on the cheek, or sharing meals. You cannot transmit it by being in the same room with family members. However, it can spread through sexual contact, sharing needles, or from mother to baby through breastfeeding. Taking proper precautions protects your loved ones from infection.
Most people do not need HTLV-II testing unless they have specific risk factors. Testing makes sense if you have a history of injection drug use, have sexual partners who inject drugs, or belong to high-risk populations. Your doctor may also order testing if you plan to donate blood or organs. Talk to your healthcare provider about whether testing is appropriate for your situation.
Hairy cell leukemia is a rare, slow-growing blood cancer that affects white blood cells called B cells. Some research has found HTLV-II in patients with this condition, but the connection is not fully understood. Most people with HTLV-II never develop hairy cell leukemia or any other cancer. The vast majority of infected individuals remain healthy throughout their lives.
Breastfeeding is not recommended if you have HTLV-II because the virus can pass to your baby through breast milk. Formula feeding is the safer choice for your infant. Talk to your obstetrician before delivery to create a feeding plan. In countries where formula is safe and affordable, avoiding breastfeeding greatly reduces the risk of transmission to your child.
For most people, HTLV-II does not cause noticeable problems with immune function. The virus infects certain immune cells but typically does not weaken your overall ability to fight infections. Unlike HIV, HTLV-II does not cause acquired immune deficiency. Regular monitoring with your doctor can catch any changes early if they do occur.
It usually takes several weeks to a few months after infection for your body to produce detectable antibodies to HTLV-II. This period is called the window period. If you were recently exposed to the virus, you may need to wait and retest later for accurate results. Your doctor can advise you on the right timing for testing based on your situation.
Yes, you should inform all your healthcare providers about your HTLV-II status. This information helps them make better decisions about your care and prevents you from donating blood or organs. Your medical team can monitor you for any rare complications. Healthcare information is confidential and protected by law, so your diagnosis will remain private.